Last 12 months
Inside the activity.
11 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 2 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 3 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2021 Filed Feb 2, 2021 00:00 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 2,353 | $14.28 | $33,600.84 |
DisclosureSEC source: 0000899243-21-003893 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,123 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 22:00 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 3,025 | $11.30 | $34,182.50 |
DisclosureSEC source: 0000899243-21-000118 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,476 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| December 10, 2020 Filed Dec 12, 2020 00:00 UTC |
Schafer KlausDirector
|
PurchaseCommon Stock, par value $0.0001 | 2,000 | $11.99 | $23,980.00 |
DisclosureSEC source: 0000899243-20-033630 · doc4.xml · nonDerivative · entry 1 Schafer Klaus · CIK 0001705904 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,900 Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 00:05 UTC |
Hodges PhilipDirector
|
SaleCommon Stock, par value $0.0001 | 1,227 | $13.54 | $16,613.58 |
DisclosureSEC source: 0000899243-20-032576 · doc4.xml · nonDerivative · entry 2 Hodges Philip · CIK 0001705562 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.51 to $13.59, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The shares of Common Stock are owned directly by Redmont Venture Partners, Inc. The reporting person has sole voting and dispositive control with respect to all securities held by Redmont Venture Partners, Inc. and may be deemed to be the beneficial owner of the securities held by Redmont Venture Partners, Inc. The reporting person disclaims beneficial ownership of the securities held by Redmont Venture Partners, Inc. except to the extent of his pecuniary interest therein. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 00:05 UTC |
GILL JOHNDirector
|
SaleCommon Stock, par value $0.0001 | 8,425 | $11.92 | $100,426.00 |
DisclosureSEC source: 0000899243-20-032575 · doc4.xml · nonDerivative · entry 1 GILL JOHN · CIK 0001409939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,199 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 00:05 UTC |
Hodges PhilipDirector
|
SaleCommon Stock, par value $0.0001 | 2,500 | $12.00 | $30,000.00 |
DisclosureSEC source: 0000899243-20-032576 · doc4.xml · nonDerivative · entry 1 Hodges Philip · CIK 0001705562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,731 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 00:05 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 2,243 | $12.23 | $27,431.89 |
DisclosureSEC source: 0000899243-20-032574 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,501 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 19:00 UTC |
Drutz DavidDirector
|
Exercise / conversionStock Options (option to buy) · Derivative | 60 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0000899243-20-031318 · doc4.xml · derivative · entry 3 Drutz David · CIK 0001428764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60 shares Expires 2020-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 7, 2018. F1 · derivative.exercise_date: This option was previously reported as covering 1,791 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 7, 2018. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 19:00 UTC |
Drutz DavidDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 60 | $2.40 | $144.00 |
DisclosureSEC source: 0000899243-20-031318 · doc4.xml · nonDerivative · entry 1 Drutz David · CIK 0001428764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 23:00 UTC |
Pisano WayneDirector
|
SaleCommon Stock, par value $0.0001 | 10,352 | $9.90 | $102,484.80 |
DisclosureSEC source: 0000899243-20-031030 · doc4.xml · nonDerivative · entry 1 Pisano Wayne · CIK 0001743611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,498 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.16, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 23:00 UTC |
Harris Matthew ScottDirector
|
SaleCommon Stock, par value $0.0001 | 4,015 | $10.02 | $40,230.30 |
DisclosureSEC source: 0000899243-20-031029 · doc4.xml · nonDerivative · entry 1 Harris Matthew Scott · CIK 0001787762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,069 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.16, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 23:00 UTC |
Schafer KlausDirector
|
SaleCommon Stock, par value $0.0001 | 10,150 | $9.91 | $100,586.50 |
DisclosureSEC source: 0000899243-20-031031 · doc4.xml · nonDerivative · entry 1 Schafer Klaus · CIK 0001705904 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,900 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $10.16, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 30, 2020 Filed Nov 2, 2020 23:00 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 2,015 | $11.45 | $23,071.75 |
DisclosureSEC source: 0000899243-20-030113 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,744 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 22:00 UTC |
Garg Vipin KDirector · President & CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 2,015 | $13.20 | $26,598.00 |
DisclosureSEC source: 0000899243-20-026921 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,759 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 22:00 UTC |
Pisano WayneDirector
|
GrantStock Options (option to buy) · Derivative | 25,500 | $0.00 Strike: $12.03 | $0.00 |
DisclosureSEC source: 0000899243-20-026413 · doc4.xml · derivative · entry 1 Pisano Wayne · CIK 0001743611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock, par value $0.0001 · 25,500 shares Expires 2030-09-24 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 18:00 UTC |
Drutz DavidDirector
|
GrantStock Options (option to buy) · Derivative | 25,500 | $0.00 Strike: $12.03 | $0.00 |
DisclosureSEC source: 0000899243-20-026411 · doc4.xml · derivative · entry 1 Drutz David · CIK 0001428764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock, par value $0.0001 · 25,500 shares Expires 2030-09-24 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 22:00 UTC |
GILL JOHNDirector
|
GrantStock Options (option to buy) · Derivative | 25,500 | $0.00 Strike: $12.03 | $0.00 |
DisclosureSEC source: 0000899243-20-026409 · doc4.xml · derivative · entry 1 GILL JOHN · CIK 0001409939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock, par value $0.0001 · 25,500 shares Expires 2030-09-24 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 22:00 UTC |
Hodges PhilipDirector
|
GrantStock Options (option to buy) · Derivative | 25,500 | $0.00 Strike: $12.03 | $0.00 |
DisclosureSEC source: 0000899243-20-026415 · doc4.xml · derivative · entry 1 Hodges Philip · CIK 0001705562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock, par value $0.0001 · 25,500 shares Expires 2030-09-24 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 22:00 UTC |
SAYARE MITCHELDirector
|
GrantStock Options (option to buy) · Derivative | 25,500 | $0.00 Strike: $12.03 | $0.00 |
DisclosureSEC source: 0000899243-20-026414 · doc4.xml · derivative · entry 1 SAYARE MITCHEL · CIK 0001201196 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock, par value $0.0001 · 25,500 shares Expires 2030-09-24 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 22:00 UTC |
Jorkasky DianeDirector
|
GrantStock Options (option to buy) · Derivative | 9,500 | $0.00 Strike: $12.03 | $0.00 |
DisclosureSEC source: 0000899243-20-026412 · doc4.xml · derivative · entry 1 Jorkasky Diane · CIK 0001527204 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock, par value $0.0001 · 9,500 shares Expires 2030-09-24 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 22:00 UTC |
Schafer KlausDirector
|
GrantStock Options (option to buy) · Derivative | 25,500 | $0.00 Strike: $12.03 | $0.00 |
DisclosureSEC source: 0000899243-20-026410 · doc4.xml · derivative · entry 1 Schafer Klaus · CIK 0001705904 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock, par value $0.0001 · 25,500 shares Expires 2030-09-24 F1 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 24, 2020, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
Pisano WayneDirector
|
Exercise / conversionRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028537 · doc4.xml · derivative · entry 2 Pisano Wayne · CIK 0001743611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. F2 · derivative.expiration_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
Pisano WayneDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028537 · doc4.xml · nonDerivative · entry 1 Pisano Wayne · CIK 0001743611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 19:00 UTC |
Drutz DavidDirector
|
Exercise / conversionRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028538 · doc4.xml · derivative · entry 3 Drutz David · CIK 0001428764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. F3 · derivative.expiration_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 19:00 UTC |
Drutz DavidDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028538 · doc4.xml · nonDerivative · entry 1 Drutz David · CIK 0001428764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
GILL JOHNDirector
|
Exercise / conversionRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028539 · doc4.xml · derivative · entry 2 GILL JOHN · CIK 0001409939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. F2 · derivative.expiration_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
GILL JOHNDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028539 · doc4.xml · nonDerivative · entry 1 GILL JOHN · CIK 0001409939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
SAYARE MITCHELDirector
|
Exercise / conversionRestricted Stock Units ("RSUs") · Derivative | 25,275 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028540 · doc4.xml · derivative · entry 2 SAYARE MITCHEL · CIK 0001201196 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: On June 25, 2020, the reporting person was granted 25,275 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. F2 · derivative.expiration_date: On June 25, 2020, the reporting person was granted 25,275 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
SAYARE MITCHELDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 25,275 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028540 · doc4.xml · nonDerivative · entry 1 SAYARE MITCHEL · CIK 0001201196 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
Schafer KlausDirector
|
Exercise / conversionRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028536 · doc4.xml · derivative · entry 2 Schafer Klaus · CIK 0001705904 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. F2 · derivative.expiration_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
Schafer KlausDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028536 · doc4.xml · nonDerivative · entry 1 Schafer Klaus · CIK 0001705904 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
Hodges PhilipDirector
|
Exercise / conversionRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028535 · doc4.xml · derivative · entry 2 Hodges Philip · CIK 0001705562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. F2 · derivative.expiration_date: On June 25, 2020, the reporting person was granted 16,850 restricted stock units, which vested in full at the Company's 2020 annual meeting of stockholders on September 24, 2020. Read SEC document |
| September 24, 2020 Filed Oct 16, 2020 23:00 UTC |
Hodges PhilipDirector
|
Exercise / conversionCommon Stock, par value $0.0001 | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-028535 · doc4.xml · nonDerivative · entry 1 Hodges Philip · CIK 0001705562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2020 Filed Aug 31, 2020 22:01 UTC |
Garg Vipin KDirector · President & CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 2,015 | $17.62 | $35,504.30 |
DisclosureSEC source: 0000899243-20-023683 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,774 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 18:47 UTC |
Brown William MichaelChief Financial Officer
|
GrantCommon Stock, par value $0.0001 | 7,920 | $1.46 | $11,563.20 |
DisclosureSEC source: 0000899243-20-021212 · doc4.xml · nonDerivative · entry 1 Brown William Michael · CIK 0001742241 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,981 F1 · kind: These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2020 through July 31, 2020. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 1, 2020. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 23:00 UTC |
Harris Matthew ScottChief Medical Officer
|
GrantCommon Stock, par value $0.0001 | 8,084 | $1.46 | $11,802.64 |
DisclosureSEC source: 0000899243-20-021219 · doc4.xml · nonDerivative · entry 1 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,084 F1 · kind: These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2020 through July 31, 2020. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 1, 2020. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 22:40 UTC |
Garg Vipin KDirector · Chief Financial Officer
|
GrantCommon Stock, par value $0.0001 | 11,674 | $1.46 | $17,044.04 |
DisclosureSEC source: 0000899243-20-021205 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,789 F1 · kind: These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2020 through July 31, 2020. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 1, 2020. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 22:43 UTC |
Roberts M ScotChief Scientific Officer
|
GrantCommon Stock, par value $0.0001 | 3,859 | $1.46 | $5,634.14 |
DisclosureSEC source: 0000899243-20-021207 · doc4.xml · nonDerivative · entry 1 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,394 F1 · kind: These shares were purchased due to participation by the reporting individual in the issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2020 through July 31, 2020. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 1, 2020. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 22:06 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 2,015 | $26.06 | $52,510.90 |
DisclosureSEC source: 0000899243-20-021020 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,115 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 22:02 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 2,015 | $10.71 | $21,580.65 |
DisclosureSEC source: 0000899243-20-018161 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,130 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| June 25, 2020 Filed Jun 30, 2020 01:48 UTC |
Pisano WayneDirector
|
GrantRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-017823 · doc4.xml · derivative · entry 1 Pisano Wayne · CIK 0001743611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,850 Underlying: Common Stock · 16,850 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. F2 · derivative.expiration_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 21:54 UTC |
Drutz DavidDirector
|
GrantRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-017835 · doc4.xml · derivative · entry 1 Drutz David · CIK 0001428764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,850 Underlying: Common Stock · 16,850 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. F2 · derivative.expiration_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. Read SEC document |
| June 25, 2020 Filed Jun 30, 2020 01:50 UTC |
GILL JOHNDirector
|
GrantRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-017826 · doc4.xml · derivative · entry 1 GILL JOHN · CIK 0001409939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,850 Underlying: Common Stock · 16,850 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. F2 · derivative.expiration_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. Read SEC document |
| June 25, 2020 Filed Jun 30, 2020 01:52 UTC |
Schafer KlausDirector
|
ConversionRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-017831 · doc4.xml · derivative · entry 1 Schafer Klaus · CIK 0001705904 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,850 Underlying: Common Stock · 16,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. F2 · derivative.expiration_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. Read SEC document |
| June 25, 2020 Filed Jun 30, 2020 01:53 UTC |
Hodges PhilipDirector
|
GrantRestricted Stock Units ("RSUs") · Derivative | 16,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-017833 · doc4.xml · derivative · entry 1 Hodges Philip · CIK 0001705562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,850 Underlying: Common Stock · 16,850 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. F2 · derivative.expiration_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. Read SEC document |
| June 25, 2020 Filed Jun 30, 2020 01:48 UTC |
SAYARE MITCHELDirector
|
GrantRestricted Stock Units ("RSUs") · Derivative | 25,275 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-017824 · doc4.xml · derivative · entry 1 SAYARE MITCHEL · CIK 0001201196 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,275 Underlying: Common Stock · 25,275 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F2 · derivative.exercise_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. F2 · derivative.expiration_date: The RSUs vest in full at the Company's 2020 annual meeting of stockholders, subject to the reporting person's continued service through the vesting date, and have no expiration date. Read SEC document |
| June 15, 2020 Filed Jun 15, 2020 15:23 UTC |
VHCP Co-Investment Holdings III, LLC10% owner
VHCP Management III, LLC10% owner
VHCP Co-Investment Holdings II, LLC10% owner
VHCP Management II, LLC10% owner
Koh Bong Y10% owner
Shah Nimish P10% owner
|
PurchaseCommon Stock | 1,500,000 | $7.54 | $11,310,000.00 |
DisclosureSEC source: 0001738048-20-000003 · edgar.xml · nonDerivative · entry 1 Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 4,500,000 F1 · ownership.nature: Represents (a) 2,571,752 shares of common stock held by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (b) 256,949 shares of common stock held by VHCP Co-Investment Holdings III, LLC ("VHCP III Co"), (c) 1,189,350 shares of common stock held by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), and (d) 481,949 shares of common stock held by VHCP Co-Investment Holdings II, LLC ("VHCP II Co"). F2 · ownership.nature: VHCP Management III, LLC ("VHCPM III") is the sole general partner of VHCP III and the sole manager of VHCP III Co. VHCP Management II, LLC ("VHCPM II") is the sole general partner of VHCP II and the sole manager of VHCP II Co. Dr. Bong Koh and Nimish Shah are the voting members of VHCPM III and VHCPM II. Dr. Koh, Mr. Shah, VHCPM III and VHCPM II disclaim beneficial ownership over all shares held by VHCP III, VHCP III Co, VHCP II and VHCP II Co, except to the extent of their respective indirect pecuniary interests therein. Read SEC document |
| May 30, 2020 Filed Jun 2, 2020 23:31 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 2,015 | $9.28 | $18,699.20 |
DisclosureSEC source: 0000899243-20-014937 · doc4.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,145 F1 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock. Read SEC document |
| May 28, 2020 Filed May 28, 2020 18:34 UTC |
VHCP Co-Investment Holdings III, LLC10% owner
VHCP Management III, LLC10% owner
VHCP Co-Investment Holdings II, LLC10% owner
VHCP Management II, LLC10% owner
Koh Bong Y10% owner
Shah Nimish P10% owner
|
PurchaseCommon Stock | 173,711 | $8.87 | $1,540,816.57 |
DisclosureSEC source: 0001738048-20-000002 · edgar.xml · nonDerivative · entry 6 Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 3,000,000 F12 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.61 to $9.00, inclusive. F3 · ownership.nature: VHCP Management III, LLC ("VHCPM III") is the sole general partner of VHCP III and the sole manager of VHCP III Co. VHCP Management II, LLC ("VHCPM II") is the sole general partner of VHCP II and the sole manager of VHCP II Co. Dr. Bong Koh and Nimish Shah are the voting members of VHCPM III and VHCPM II. Dr. Koh, Mr. Shah, VHCPM III and VHCPM II disclaim beneficial ownership over all shares held by VHCP III, VHCP III Co, VHCP II and VHCP II Co, except to the extent of their respective indirect pecuniary interests therein. F13 · ownership.nature: Represents (a) 1,714,502 shares of common stock held by VHCP III, (b) 171,299 shares of common stock held by VHCP III Co, (c) 792,900 shares of common stock held by VHCP II, and (d) 321,299 shares of common stock held by VHCP II Co. Read SEC document |
| May 28, 2020 Filed May 28, 2020 18:34 UTC |
VHCP Co-Investment Holdings III, LLC10% owner
VHCP Management III, LLC10% owner
VHCP Co-Investment Holdings II, LLC10% owner
VHCP Management II, LLC10% owner
Koh Bong Y10% owner
Shah Nimish P10% owner
|
PurchaseCommon Stock | 27,763 | $7.79 | $216,273.77 |
DisclosureSEC source: 0001738048-20-000002 · edgar.xml · nonDerivative · entry 5 Venrock Healthcare Capital Partners III, L.P. · CIK 0001738048 · 10% owner VHCP Co-Investment Holdings III, LLC · CIK 0001750761 · 10% owner VHCP Management III, LLC · CIK 0001738053 · 10% owner Venrock Healthcare Capital Partners II, L.P. · CIK 0001602264 · 10% owner VHCP Co-Investment Holdings II, LLC · CIK 0001615983 · 10% owner VHCP Management II, LLC · CIK 0001602263 · 10% owner Koh Bong Y · CIK 0001615979 · 10% owner Shah Nimish P · CIK 0001698082 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Funds Disclosed balance after: 2,826,289 F10 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.61 to $8.60, inclusive. F3 · ownership.nature: VHCP Management III, LLC ("VHCPM III") is the sole general partner of VHCP III and the sole manager of VHCP III Co. VHCP Management II, LLC ("VHCPM II") is the sole general partner of VHCP II and the sole manager of VHCP II Co. Dr. Bong Koh and Nimish Shah are the voting members of VHCPM III and VHCPM II. Dr. Koh, Mr. Shah, VHCPM III and VHCPM II disclaim beneficial ownership over all shares held by VHCP III, VHCP III Co, VHCP II and VHCP II Co, except to the extent of their respective indirect pecuniary interests therein. F11 · ownership.nature: Represents (a) 1,615,227 shares of common stock held by VHCP III, (b) 161,380 shares of common stock held by VHCP III Co, (c) 746,988 shares of common stock held by VHCP II, and (d) 302,694 shares of common stock held by VHCP II Co. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.